Bastiaan Evers

4.5k total citations
39 papers, 2.4k citations indexed

About

Bastiaan Evers is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bastiaan Evers has authored 39 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Genetics. Recurrent topics in Bastiaan Evers's work include DNA Repair Mechanisms (8 papers), CRISPR and Genetic Engineering (8 papers) and PARP inhibition in cancer therapy (5 papers). Bastiaan Evers is often cited by papers focused on DNA Repair Mechanisms (8 papers), CRISPR and Genetic Engineering (8 papers) and PARP inhibition in cancer therapy (5 papers). Bastiaan Evers collaborates with scholars based in Netherlands, United States and United Kingdom. Bastiaan Evers's co-authors include Jos Jonkers, René Bernards, Roderick L. Beijersbergen, Patrick W.B. Derksen, Katarzyna Jastrzebski, Xiaoling Liu, Wipawadee Grernrum, John Zevenhoven, Cor Lieftink and Thomas Helleday and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Bastiaan Evers

38 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bastiaan Evers Netherlands 21 1.8k 995 369 246 241 39 2.4k
Phillip Shaw Switzerland 19 1.5k 0.8× 849 0.9× 338 0.9× 184 0.7× 373 1.5× 24 2.3k
Maria Rosa Bani Italy 28 1.6k 0.9× 789 0.8× 509 1.4× 384 1.6× 112 0.5× 62 2.4k
Jiaxue Wu China 28 2.0k 1.1× 675 0.7× 350 0.9× 181 0.7× 387 1.6× 53 2.6k
Peter Bouwman Netherlands 22 2.5k 1.5× 1.1k 1.1× 400 1.1× 424 1.7× 517 2.1× 42 3.4k
Daniel J. Murphy United Kingdom 22 2.2k 1.2× 843 0.8× 645 1.7× 317 1.3× 164 0.7× 43 3.0k
Oleg N. Demidov France 26 2.0k 1.1× 997 1.0× 423 1.1× 224 0.9× 126 0.5× 54 2.6k
Barbara A. Osborne United States 6 2.1k 1.2× 1.7k 1.7× 469 1.3× 365 1.5× 189 0.8× 8 3.0k
Yoko Itahana United States 24 2.0k 1.2× 896 0.9× 516 1.4× 160 0.7× 186 0.8× 40 2.6k
Gibbes R. Johnson United States 26 1.2k 0.7× 737 0.7× 176 0.5× 307 1.2× 232 1.0× 42 1.9k
Ricardo Sánchez‐Prieto Spain 26 1.3k 0.8× 696 0.7× 374 1.0× 153 0.6× 252 1.0× 74 2.1k

Countries citing papers authored by Bastiaan Evers

Since Specialization
Citations

This map shows the geographic impact of Bastiaan Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bastiaan Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bastiaan Evers more than expected).

Fields of papers citing papers by Bastiaan Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bastiaan Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bastiaan Evers. The network helps show where Bastiaan Evers may publish in the future.

Co-authorship network of co-authors of Bastiaan Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Bastiaan Evers. A scholar is included among the top collaborators of Bastiaan Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bastiaan Evers. Bastiaan Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steurer, Barbara, Roel C. Janssens, Marit E. Geijer, et al.. (2022). DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II. Nature Communications. 13(1). 3624–3624. 35 indexed citations
2.
Berns, Katrien, Joseph J. Caumanns, E. Marielle Hijmans, et al.. (2018). ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors. Oncogene. 37(33). 4611–4625. 77 indexed citations
3.
Wang, Cun, Haojie Jin, Dongmei Gao, et al.. (2018). Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer. Journal of Hepatology. 69(5). 1057–1065. 73 indexed citations
4.
O’Connor, Lenka Oplustil, Stuart L. Rulten, Aaron Cranston, et al.. (2016). The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models. Cancer Research. 76(20). 6084–6094. 60 indexed citations
5.
Herr, Patrick, Cecilia Lundin, Bastiaan Evers, et al.. (2015). A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair. Cell Discovery. 1(1). 15034–15034. 26 indexed citations
7.
Rosen, Michael J., et al.. (2010). Atlas of Surgical Techniques for the Upper Gastrointestinal Tract and Small Bowel. Elsevier eBooks.
8.
Evers, Bastiaan, Eva Schut, Eline van der Burg, et al.. (2009). A High-Throughput Pharmaceutical Screen Identifies Compounds with Specific Toxicity against BRCA2-Deficient Tumors. Clinical Cancer Research. 16(1). 99–108. 66 indexed citations
9.
Puppe, Julian, Rinske Drost, Xiaoling Liu, et al.. (2009). BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A. Breast Cancer Research. 11(4). R63–R63. 95 indexed citations
10.
Evers, Bastiaan, Ewoud N. Speksnijder, Eva Schut, et al.. (2009). A tissue reconstitution model to study cancer cell‐intrinsic and ‐extrinsic factors in mammary tumourigenesis. The Journal of Pathology. 220(1). 34–44. 12 indexed citations
11.
Boesten, Lianne S.M., Lihui Hu, Amina F.A.S. Teunisse, et al.. (2009). Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice. Atherosclerosis. 207(2). 399–404. 27 indexed citations
12.
Pietersen, Alexandra M, Bastiaan Evers, Asheeta A. Prasad, et al.. (2008). Bmi1 Regulates Stem Cells and Proliferation and Differentiation of Committed Cells in Mammary Epithelium. Current Biology. 18(14). 1094–1099. 96 indexed citations
13.
Liu, Xiaoling, Patrick W.B. Derksen, Bastiaan Evers, et al.. (2005). Conditional mouse models of breast cancer. Cancer Research. 65. 250–251. 1 indexed citations
14.
Townsend, Courtney M., R. Daniel Beauchamp, Bastiaan Evers, & Kenneth L. Mattox. (2004). Sabiston textbook of surgery 17th edition board review. Elsevier eBooks. 3 indexed citations
15.
Campagnaro, Erica, Kenneth J. Woodside, Shu‐Yuan Xiao, John A. Daller, & Bastiaan Evers. (2003). Cystosarcoma phyllodes (phyllodes tumor) of the male breast. Surgery. 133(6). 689–691. 9 indexed citations
16.
Chu, Kyo U., Bastiaan Evers, Jin Ishizuka, et al.. (1996). Short-term caloric restriction augments age-related decreases in gastrin content and release. Mechanisms of Ageing and Development. 87(1). 25–33. 1 indexed citations
17.
Townsend, Courtney M., et al.. (1995). Increases in nup 475 and c-jun Are Early Molecular Events That Precede the Adaptive Hyperplastic Response After Small Bowel Resection. Annals of Surgery. 222(1). 51–56. 13 indexed citations
18.
Chu, Kyo U., Bastiaan Evers, Jin Ishizuka, Courtney M. Townsend, & James C. Thompson. (1995). Role of Bombesin on Gut Mucosal Growth. Annals of Surgery. 222(1). 94–100. 41 indexed citations
19.
Chu, Kyo U., Shunichi Higashide, Bastiaan Evers, et al.. (1994). Bombesin Improves Survival from Methotrexate-Induced Enterocolitis. Annals of Surgery. 220(4). 570–577. 30 indexed citations
20.
Malangoni, Mark A., Bastiaan Evers, James C. Peyton, & Samuel R. Wellhausen. (1988). Reticuloendothelial clearance and splenic mononuclear cell populations after resection and autotransplantation. The American Journal of Surgery. 155(2). 298–302. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026